Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics Market 2025-2029 - Global Market Forecasts by Assay, Cause, Product, Lab and Place, with Executive and Consultant Guides" has been ...

SEATTLE, May 9, 2018 /PRNewswire/ -- Immunexpress, Inc. today announced the publication in the American Journal of Respiratory and Clinical Care Medicine of the design and results of clinical trials ...

Sepsis is the most common cause of mortality in many hospitals and is most often caused by blood stream infections. The major contributor to death is delayed initiation of effective antimicrobial ...

The FDA granted 510(k) clearance to Immunexpress for the use of its SeptiCyte™ LAB as an aid in differentiating infection-positive (sepsis) from infection-negative (systemic inflammatory response ...

Sepsis is a life-threatening condition that occurs when the body's immune system releases chemicals to fight an infection, causing widespread inflammation. If it's addressed too late, it can result in ...

The Sepsis Diagnostics Market has emerged as a critical segment within the global healthcare and in-vitro diagnostics industry, driven by the urgent need for early disease detection and improved ...

SepsisLab reduces uncertainty by suggesting the most impactful lab tests and vital signs for clinicians to prioritize Incorporating just 8% of additional data improved sepsis prediction accuracy by 11 ...

Sepsis is the Achilles’ heel of health care. Despite being relatively unknown to the public, it is a top killer in hospitals and the cost burden is crushing to our healthcare system. More and more, ...

DENVER (CBS4) - Health officials looking to cut down the incidence of sepsis in Colorado are hoping a mobile lab will teach medical staff how to catch and treat it. As part of the program, a high-tech ...

JENA, Germany--(BUSINESS WIRE)--SIRS-Lab today announced that the EU regulatory authorities have granted the CE mark for VYOO, a molecular diagnostic test for pathogen detection in sepsis. With VYOO, ...